Dynamic Technology Lab Private Ltd Buys Shares of 10,000 SPDR S&P Biotech ETF $XBI

Dynamic Technology Lab Private Ltd bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 10,000 shares of the exchange traded fund’s stock, valued at approximately $1,219,000.

Several other institutional investors and hedge funds have also modified their holdings of XBI. JPMorgan Chase & Co. lifted its stake in shares of SPDR S&P Biotech ETF by 27.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock valued at $1,356,582,000 after purchasing an additional 2,900,633 shares during the last quarter. Wells Fargo & Company MN lifted its stake in shares of SPDR S&P Biotech ETF by 75.7% in the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after purchasing an additional 1,536,122 shares during the last quarter. Assetmark Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 1,042,265.6% in the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after purchasing an additional 635,782 shares during the last quarter. Greenwoods Asset Management Hong Kong Ltd. acquired a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at $55,613,000. Finally, Ameriprise Financial Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 123.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after purchasing an additional 481,408 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 0.8%

XBI stock opened at $133.79 on Friday. SPDR S&P Biotech ETF has a 1 year low of $80.90 and a 1 year high of $139.19. The company has a fifty day simple moving average of $132.63 and a 200 day simple moving average of $127.12. The firm has a market cap of $8.54 billion, a PE ratio of 11.47 and a beta of 0.85.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.